Literature DB >> 9059351

Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.

A Zidan1, J S Christie Brown, D Peston, S Shousha.   

Abstract

AIMS: To assess the suitability of core biopsy specimens for the immunohistological assessment of oestrogen and progesterone receptors in breast carcinoma.
METHODS: Thirty consecutive cases of clinically palpable breast carcinoma, from which both core and excision biopsy specimens were available, were examined. Routinely processed paraffin wax sections were stained using the specific monoclonal antibodies 1D5 (Dako) for oestrogen receptor and NCL-PGR (Novocastra) for progesterone receptor, after an antigen retrieval step using a pressure cooker. Staining results were assessed using the H score system with the results being expressed as negative, weakly positive, moderately positive or strongly positive.
RESULTS: Twenty six biopsy specimens contained enough tumour tissue for assessment. Absolute agreement between scoring categories was seen in 19 (73%) cases for oestrogen receptors. However, when all positive categories were added together, agreement between core and excision biopsy specimens increased to 93% (24 cases). Disagreement was seen only in two cases which stained positive in the core biopsy specimens and negative in the excision biopsy specimens. For progesterone receptors, the absolute agreement between all scoring categories was seen only in 11 (42%) cases. When all positive categories were considered together, agreement increased to 69% (18 cases). Five cases were progesterone receptor positive in core but not in excisional biopsy specimens, while three cases were negative in core but positive in excisional biopsy specimens.
CONCLUSIONS: The results suggest that core biopsy specimens can be reliably used for oestrogen receptor assessment, but are less reliable for progesterone receptor assessment, probably because of a greater heterogeneity of progesterone receptor staining.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059351      PMCID: PMC499707          DOI: 10.1136/jcp.50.1.27

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment.

Authors:  S C Low; A R Dixon; J Bell; I O Ellis; C W Elston; J F Robertson; R W Blamey
Journal:  Br J Surg       Date:  1992-12       Impact factor: 6.939

2.  Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis.

Authors:  P Vielh; H Magdelénat; V Mosseri; Y Remvikos; L di Bonito
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

3.  The role of pre-operative diagnosis in breast cancer.

Authors:  S E Pinder; C W Elston; I O Ellis
Journal:  Histopathology       Date:  1996-06       Impact factor: 5.087

Review 4.  Primary management of carcinoma of the breast.

Authors:  N P Sacks; M Baum
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

5.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

6.  A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples.

Authors:  H Goulding; S Pinder; P Cannon; D Pearson; R Nicholson; D Snead; J Bell; C W Elston; J F Robertson; R W Blamey
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

7.  Randomized comparison of fine-needle aspiration cytology and Biopty-Cut needle biopsy after unsatisfactory initial cytology of discrete breast lesions.

Authors:  N J Carty; D Ravichandran; C Carter; S Mudan; G T Royle; I Taylor
Journal:  Br J Surg       Date:  1994-09       Impact factor: 6.939

8.  Role of fine-needle aspiration cytology and needle-core biopsy in the diagnosis of lobular carcinoma of the breast.

Authors:  G P Sadler; S McGee; N S Dallimore; I J Monypenny; A G Douglas-Jones; K Lyons; K Horgan
Journal:  Br J Surg       Date:  1994-09       Impact factor: 6.939

9.  Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing.

Authors:  P Sannino; S Shousha
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

10.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

Authors:  T J Powles; T F Hickish; A Makris; S E Ashley; M E O'Brien; V A Tidy; S Casey; A G Nash; N Sacks; D Cosgrove
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

View more
  13 in total

1.  Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.

Authors:  I O Ellis; S Humphreys; M Michell; S E Pinder; C A Wells; H D Zakhour
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 2.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

Review 3.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Authors:  Zsolt Hodi; Jayeta Chakrabarti; Andrew H S Lee; John E Ronan; Christopher W Elston; Kwok Leung Cheung; John F R Robertson; Ian O Ellis
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

4.  Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis.

Authors:  M S Khan; A R Dodson; M K Heatley
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

5.  Reliability of receptor assessment on core needle biopsy in breast cancer patients.

Authors:  S C Seferina; M Nap; F van den Berkmortel; J Wals; A C Voogd; V C G Tjan-Heijnen
Journal:  Tumour Biol       Date:  2012-12-27

6.  Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.

Authors:  Anne Grote; Mahmoud Abbas; Nina Linder; Hans H Kreipe; Johan Lundin; Friedrich Feuerhake
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

7.  Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.

Authors:  Xiaosong Chen; Long Sun; Yan Mao; Siji Zhu; Jiayi Wu; Ou Huang; Yafen Li; Weiguo Chen; Jianhua Wang; Ying Yuan; Xiaochun Fei; Xiaolong Jin; Kunwei Shen
Journal:  BMC Cancer       Date:  2013-08-19       Impact factor: 4.430

8.  The Core Needle and Surgical Biopsy Concordance to Detect Estrogen, Progesterone, and Her-2 Receptors in Breast Cancer: A Comparative Study.

Authors:  Fereshteh Ensani; Ramesh Omranipour; Isa Jahanzad; Azadeh Jafari; Shima Nafarzadeh; Pouyan Aminishakib
Journal:  Iran J Pathol       Date:  2017-07-01

9.  Accuracy of estrogen and progesterone receptor assessment in core needle biopsy specimens of breast cancer.

Authors:  Ramesh Omranipour; Sadaf Alipour; Maryam Hadji; Forouzandeh Fereidooni; Issa Jahanzad; Khojasteh Bagheri
Journal:  Iran Red Crescent Med J       Date:  2013-06-05       Impact factor: 0.611

10.  A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.

Authors:  Sirwan M Hadad; Lee B Jordan; Pankaj G Roy; Colin A Purdie; Takayuki Iwamoto; Lajos Pusztai; Stacy L Moulder-Thompson; Alastair M Thompson
Journal:  BMC Cancer       Date:  2016-09-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.